Hsu AP, Sampaio EF, Kahn J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vinh DC, Patel SY, Uzel G, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115(8):2653–5.

Article  Google Scholar 

Bigley V, Haniffa M, Doulatov S, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med. 2011;208(2):227–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte B and NK lymphoid deficiency. Blood. 2011;118(10):2656–8.

Article  CAS  PubMed  Google Scholar 

Mansour S, Connell F, Steward C, et al. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Am J Med Genet A. 2010;152A(9):2287–96.

Article  PubMed  Google Scholar 

Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43(10):929–31.

Article  CAS  PubMed  Google Scholar 

Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donadieu J, Lamant M, Fieschi C, et al. Natural history of GATA2 deficieny in a survey of 79 French and Belgian patients. Haematologica. 2018;103(8):1278–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crispino JD, Horwitz MS. GATA factor mutations in hematologic disease. Blood. 2017;129(15):2103–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orkin SH. Gata-binding transcription factors in hematopoietic cells. Blood. 1992;80(3):575–81.

Article  CAS  PubMed  Google Scholar 

Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371(6494):221–6.

Article  CAS  PubMed  Google Scholar 

Tsai FY, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 1997;371(6494):221–6.

Google Scholar 

Suzuki M, Kobayashi-Osaki M, Tsutsumi S, et al. GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation. Genes Cells. 2013;18(11):921–33.

Article  CAS  PubMed  Google Scholar 

de Pater E, Kaimakis P, Vink CS, et al. Gata2 is required for HSC generation and survival. J Exp Med. 2013;210:2843–50.

Article  PubMed  PubMed Central  Google Scholar 

McReynolds LJ, Calvo KR, Holland SM. Germline GATA2 Mutation and Bone Marrow Failure. Hematol Oncol Clin North Am. 2018;32(4):713–28.

Article  PubMed  PubMed Central  Google Scholar 

Kotmayer L, Romero-Moya D, Marin-Bejar O, et al. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects. Br J Haematol. 2022;199(4):482–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wlodarski MS, Collin M, Horowitz MS. GATA2 deficiency and related myeloid neoplasms. Semin Hematol. 2017;54:81–6.

Article  PubMed  PubMed Central  Google Scholar 

Wehr C, Grotius K, Casadei S, Bleckmann D, Bode SFN, Frye BC, et al. A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing. Blood. 2018;132(11):1211–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kozyra EJ, Pastor VB, Lefkopoulos S, et al. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia. 2020;34(10):2673–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh P, Heer M, Resteu A, Mikulasova A, et al. GATA2 Deficiency Phenotype Associated With Tandem Duplication GATA2 and Over-Expression of GATA2-As1. Blood Adv. 2021;5(24):5631–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shiba N, Funato M, Ohki K, et al. Mutations of the GATA2 and CEBPA Genes in Paediatric Acute Myeloid Leukaemia. B J Haematol. 2014;164:142–5.

Article  CAS  Google Scholar 

Dickinson RE, Milne P, Jardine L, et al. The evolution of cellular deficiency in GATA2 mutation. Blood. 2014;123(6):863–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Homan CC, Venugopal P, Arts P, et al. GATA2 deficiency syndrome: a decade of discovery. Hum Mutat. 2021;42(11):1399–421.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calvo KR, Hickstein DD, Holland SM. MonoMAC and GATA2 deficiency: overlapping clinical and pathological features with aplastic anemia and idiopathic CD4+ lymphocytopenia. Haematologica. 2012;97(4):e12–3.

Article  PubMed Central  Google Scholar 

Ganapathi KA, Townsley DM, Hsu AP, et al. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2015;125(1):56–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Wlodarski MW, Hirabayashi S, Pastor V, et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127(11):1387–97. Found high rates of GATA2 deficiency in pediatric patients with MDS and monosomy 7 (37% of all cases and 72% of adolescents), indicating that monosomy 7 may be a sign of underlying GATA2 deficiency in patients presenting with MDS.

Hirabayashi S, Wlodarski MW, Kozyra E, Niemeyer CM. Heterogeneity of GATA2-related myeloid neoplasms. Int J Hematol. 2017;106(2):175–82.

Article  CAS  PubMed  Google Scholar 

Stieglitz E, Loh ML. Pediatric MDS: GATA screen the germline. Blood. 2016;127(11):1377–8.

Article  CAS  PubMed  Google Scholar 

• West RR, Calvo KR, Embree LJ, et al. ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome. Blood Adv. 2022;6(3):793–807. Performed cytogenetic and mutational analysis on 106 patients with GATA2 deficiency and found high rates of monsomy 7, trisomy 8, and der(1;7). Mutations in STAG2 and ASXL1 were the most commonly identified somatic mutations.

Kozyra EJ, Gohring G, Hickstein DD, et al. Association of unbalanced translocation der(1;7) with germline GATA2 mutations. Blood. 2021;138(23):2441–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bodor C, Renneville A, Smith M, et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica. 2012;97(6):890–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

West RR, Hsu AP, Holland SM, Cuellar-Rodriguez J, Hickstein DD. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica. 2014;99(2):276–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pastor Loyola VB, Hirabayashi J, Pohl S, et al. Somatic genetic and epigenetic architecture of myelodysplastic syndromes arising from GATA2 deficiency. Blood. 2015;126(23):299.

Article  Google Scholar 

Fisher KE, Hsu AP, Williams CL, et al. Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency. Blood Adv. 2017;1(7):443–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Churpek JE, Pyrtel K, Kanchi KL, et al. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood. 2015;126(22):2484–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drazer MW, Kadri S, Sukhanova M, et al. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Adv. 2018;2(2):146–50.

Article  CAS  PubMed  PubMed Central  Google Scholar